| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: Non-randomised comparison of weekly versus four-weekly schedules – less pain, same gain
|
Kerr, D. J.
|
|
2000
|
11 |
8 |
p. 947-955
|
article
|
| 2 |
Adjuvant chemotherapy with 5-fluorouracil, L-folinic acid and levamisole for patients with colorectal cancer: Non-randomised comparison of weekly versus four-weekly schedules — less pain, same gain
|
Kerr, D.J.
|
|
|
11 |
8 |
p. 947-956
|
article
|
| 3 |
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin
|
Vermorken, J. B.
|
|
2000
|
11 |
8 |
p. 1035-1040
|
article
|
| 4 |
A phase II study of high-dose epirubicin in ovarian cancer patients previously treated with cisplatin
|
Vermorken, J.B.
|
|
|
11 |
8 |
p. 1035-1040
|
article
|
| 5 |
A row on euthanasia goes on while popular support increases
|
|
|
|
11 |
8 |
p. 904-905
|
article
|
| 6 |
Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature
|
Ellis, P. M.
|
|
2000
|
11 |
8 |
p. 939-945
|
article
|
| 7 |
Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature
|
Ellis, P.M.
|
|
|
11 |
8 |
p. 939-946
|
article
|
| 8 |
Awards, appointments
|
|
|
|
11 |
8 |
p. 905
|
article
|
| 9 |
Book review
|
Orecchia, R.
|
|
|
11 |
8 |
p. 1072
|
article
|
| 10 |
Book review
|
Armitage, J.
|
|
|
11 |
8 |
p. 908
|
article
|
| 11 |
Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey
|
Stone, P.
|
|
2000
|
11 |
8 |
p. 971-975
|
article
|
| 12 |
Cancer-related fatigue: Inevitable, unimportant and untreatable? Results of a multi-centre patient survey
|
Stone, P.
|
|
|
11 |
8 |
p. 971-976
|
article
|
| 13 |
Can mitomycin C represent a valid partner for 5-fluorouracil in second-line chemotherapy of colorectal cancer?
|
Tassinari, D.
|
|
2000
|
11 |
8 |
p. 1071
|
article
|
| 14 |
Can mitomycin C represent a valid partner for 5-fluorouracil in second-line chemotherapy of colorectal cancer?
|
Tassinari, D.
|
|
|
11 |
8 |
p. 1071
|
article
|
| 15 |
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
|
Sessa, C.
|
|
2000
|
11 |
8 |
p. 977-983
|
article
|
| 16 |
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex
|
Sessa, C.
|
|
|
11 |
8 |
p. 977-984
|
article
|
| 17 |
Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancer
|
Lombardi, D.
|
|
2000
|
11 |
8 |
p. 1041-1043
|
article
|
| 18 |
Combination chemotherapy with navelbine and continuous infusion of 5-fluorouracil in metastatic, chemotherapy refractory breast cancer
|
Lombardi, D.
|
|
|
11 |
8 |
p. 1041-1044
|
article
|
| 19 |
Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
|
Harrison, G.
|
|
2000
|
11 |
8 |
p. 999-1006
|
article
|
| 20 |
Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial
|
Harrison, G.
|
|
|
11 |
8 |
p. 999-1006
|
article
|
| 21 |
Contents of the next issue
|
|
|
|
11 |
8 |
p. xiii
|
article
|
| 22 |
Copyright
|
|
|
|
11 |
8 |
p. xi
|
article
|
| 23 |
Editorial Board
|
|
|
|
11 |
8 |
p. xii
|
article
|
| 24 |
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study
|
Pagani, O.
|
|
2000
|
11 |
8 |
p. 985-991
|
article
|
| 25 |
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: A multicentric phase I–II study
|
Pagani, O.
|
|
|
11 |
8 |
p. 985-992
|
article
|
| 26 |
F. Cavalli, H. Hansen, S. B. Kaye (eds)., Textbook of Medical Oncology
|
Armitage, J.
|
|
2000
|
11 |
8 |
p. 908
|
article
|
| 27 |
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group
|
Maiello, E.
|
|
2000
|
11 |
8 |
p. 1045-1051
|
article
|
| 28 |
5-Fluorouracil and folinic acid with or without CPT-11 in advanced colorectal cancer patients: A multicenter randomised phase II study of the Southern Italy Oncology Group
|
Maiello, E.
|
|
|
11 |
8 |
p. 1045-1052
|
article
|
| 29 |
France and Council of Europe against gene-patenting law
|
|
|
|
11 |
8 |
p. 903-904
|
article
|
| 30 |
France first in health care
|
|
|
|
11 |
8 |
p. 903
|
article
|
| 31 |
General decline of cancer incidence in US
|
|
|
|
11 |
8 |
p. 903
|
article
|
| 32 |
General decline of cancer incidence in US; France first in health care; France and Council of Europe against gene-patenting law; Task force on German fraud disillusioned; A row on euthanasia goes on while popular support increases; Awards, appointments; Perhaps not everyone knows that...
|
|
|
2000
|
11 |
8 |
p. 903-907
|
article
|
| 33 |
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia
|
Rohatiner, A. Z. S.
|
|
2000
|
11 |
8 |
p. 1007-1015
|
article
|
| 34 |
High-dose treatment with autologous bone marrow support as consolidation of first remission in younger patients with acute myelogenous leukaemia
|
Rohatiner, A.Z.S.
|
|
|
11 |
8 |
p. 1007-1016
|
article
|
| 35 |
`Hold the Mayo': Solid facts or pulp fiction?
|
Punt, C. J. A.
|
|
2000
|
11 |
8 |
p. 919-920
|
article
|
| 36 |
‘Hold the Mayo’: Solid facts or pulp fiction?
|
Punt, C.J.A.
|
|
|
11 |
8 |
p. 919-920
|
article
|
| 37 |
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil–leucovorin combination
|
Cascinu, S.
|
|
2000
|
11 |
8 |
p. 1053-1056
|
article
|
| 38 |
Immunohistochemical determination of p53 protein does not predict clinical response in advanced colorectal cancer with low thymidylate synthase expression receiving a bolus 5-fluorouracil—leucovorin combination
|
Cascinu, S.
|
|
|
11 |
8 |
p. 1053-1056
|
article
|
| 39 |
In this issue
|
|
|
|
11 |
8 |
p. xiii
|
article
|
| 40 |
J. Dobbs, A. Barrett, D. Ash (eds)., Practical Radiotherapy Planning
|
Orecchia, R.
|
|
2000
|
11 |
8 |
p. 1072
|
article
|
| 41 |
Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
|
Safra, T.
|
|
2000
|
11 |
8 |
p. 1029-1033
|
article
|
| 42 |
Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2
|
Safra, T.
|
|
|
11 |
8 |
p. 1029-1034
|
article
|
| 43 |
Perhaps not everyone knows that…
|
|
|
|
11 |
8 |
p. 905-907
|
article
|
| 44 |
QUOROM and the search for an updated `clinical method' in the era of evidence-based medicine
|
Casali, P. G.
|
|
2000
|
11 |
8 |
p. 923-925
|
article
|
| 45 |
QUOROM and the search for an updated ‘clinical method’ in the era of evidence-based medicine
|
Casali, P.G.
|
|
|
11 |
8 |
p. 923-925
|
article
|
| 46 |
QUOROM – another step forwards
|
Williams, C.
|
|
2000
|
11 |
8 |
p. 921-922
|
article
|
| 47 |
QUOROM — another step forwards
|
Williams, C.
|
|
|
11 |
8 |
p. 921-922
|
article
|
| 48 |
Raltitrexed (`Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancer
|
Botwood, N.
|
|
2000
|
11 |
8 |
p. 1023-1028
|
article
|
| 49 |
Raltitrexed (‘Tomudex’) and radiotherapy can be combined as postoperative treatment for rectal cancer
|
Botwood, N.
|
|
|
11 |
8 |
p. 1023-1028
|
article
|
| 50 |
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors
|
Colleoni, M.
|
|
2000
|
11 |
8 |
p. 1057-1059
|
article
|
| 51 |
Response to primary chemotherapy in breast cancer patients with tumors not expressing estrogen and progesterone receptors
|
Colleoni, M.
|
|
|
11 |
8 |
p. 1057-1060
|
article
|
| 52 |
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients
|
Baars, A.
|
|
2000
|
11 |
8 |
p. 965-970
|
article
|
| 53 |
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: Experience in 81 patients
|
Baars, A.
|
|
|
11 |
8 |
p. 965-970
|
article
|
| 54 |
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: Case report and literature review
|
Vanhees, S. L.
|
|
2000
|
11 |
8 |
p. 1061-1065
|
article
|
| 55 |
Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: Case report and literature review
|
Vanhees, S.L.
|
|
|
11 |
8 |
p. 1061-1066
|
article
|
| 56 |
Table of Contents
|
|
|
|
11 |
8 |
p. x-xi
|
article
|
| 57 |
Tamoxifen-induced severe hypertriglyceridemia and pancreatitis
|
Elisaf, M. S.
|
|
2000
|
11 |
8 |
p. 1067-1069
|
article
|
| 58 |
Tamoxifen-induced severe hypertriglyceridemia and pancreatitis
|
Elisaf, M.S.
|
|
|
11 |
8 |
p. 1067-1070
|
article
|
| 59 |
Task force on German fraud disillusioned
|
|
|
|
11 |
8 |
p. 904
|
article
|
| 60 |
The optimal 5-fluorouracil regimen for the adjuvant therapy of colon cancer: Where to from here?
|
Michael, M.
|
|
2000
|
11 |
8 |
p. 915-918
|
article
|
| 61 |
The optimal 5-fluorouracil regimen for the adjuvant therapy of colon cancer: Where to from here?
|
Michael, M.
|
|
|
11 |
8 |
p. 915-918
|
article
|
| 62 |
Therapeutic management of primary central nervous system lymphoma: Lessons from prospective trials
|
Ferreri, A. J. M.
|
|
2000
|
11 |
8 |
p. 927-937
|
article
|
| 63 |
Therapeutic management of primary central nervous system lymphoma: Lessons from prospective trials
|
Ferreri, A.J.M.
|
|
|
11 |
8 |
p. 927-937
|
article
|
| 64 |
The regulation of tobacco and tobacco smoke
|
Gray, N.
|
|
2000
|
11 |
8 |
p. 909-914
|
article
|
| 65 |
The regulation of tobacco and tobacco smoke
|
Gray, N.
|
|
|
11 |
8 |
p. 909-914
|
article
|
| 66 |
Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993
|
Levi, F.
|
|
2000
|
11 |
8 |
p. 957-963
|
article
|
| 67 |
Trends in survival for patients diagnosed with cancer in Vaud, Switzerland, between 1974 and 1993
|
Levi, F.
|
|
|
11 |
8 |
p. 957-964
|
article
|
| 68 |
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors
|
Bajetta, E.
|
|
2000
|
11 |
8 |
p. 1017-1022
|
article
|
| 69 |
Tumor response and estrogen suppression in breast cancer patients treated with aromatase inhibitors
|
Bajetta, E.
|
|
|
11 |
8 |
p. 1017-1022
|
article
|
| 70 |
Vinorelbine–gemcitabine in advanced non-small-cell lung cancer (NSCLC): An AASLC phase II trial
|
Krajnik, G.
|
|
2000
|
11 |
8 |
p. 993-998
|
article
|
| 71 |
Vinorelbine—gemcitabine in advanced non-small-cell lung cancer (NSCLC): An AASLC phase II trial
|
Krajnik, G.
|
|
|
11 |
8 |
p. 993-998
|
article
|
Journal description